Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
OrthopedicSpinal Implant

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1777531

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1777531

Sacroiliac Joint Fusion

PUBLISHED:
PAGES: 374 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Sacroiliac Joint Fusion Market to Reach US$2.5 Billion by 2030

The global market for Sacroiliac Joint Fusion estimated at US$838.3 Million in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 20.4% over the analysis period 2024-2030. Degenerative Sacroiliitis, one of the segments analyzed in the report, is expected to record a 22.3% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Sacral Disruption segment is estimated at 16.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$228.4 Million While China is Forecast to Grow at 26.9% CAGR

The Sacroiliac Joint Fusion market in the U.S. is estimated at US$228.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$589.4 Million by the year 2030 trailing a CAGR of 26.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.0% and 18.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.3% CAGR.

Global Sacroiliac Joint Fusion Market - Key Trends & Drivers Summarized

Why Is Sacroiliac Joint Fusion Gaining Prominence In Orthopedic Treatments?

Sacroiliac (SI) joint dysfunction is a significant cause of lower back pain, affecting millions of people worldwide. As awareness of SI joint-related pain grows, sacroiliac joint fusion is becoming a widely adopted treatment option for patients who do not respond to conservative therapies such as physical therapy, pain management, and injections. The procedure involves stabilizing the SI joint using implants or bone grafts to reduce pain and improve mobility. The increasing prevalence of degenerative joint diseases, trauma-related injuries, and lifestyle factors such as obesity and prolonged sitting are fueling demand for SI joint fusion surgeries. Additionally, advancements in minimally invasive surgical techniques are making the procedure safer, reducing recovery times, and improving patient outcomes. With an aging global population and rising healthcare expenditure, the sacroiliac joint fusion market is experiencing strong growth.

What Technological Innovations Are Transforming Sacroiliac Joint Fusion Procedures?

Advancements in medical technology are significantly enhancing the precision and effectiveness of SI joint fusion procedures. The development of minimally invasive surgical (MIS) techniques has reduced operative times, post-surgical pain, and recovery periods. Image-guided navigation systems and robotic-assisted surgery are improving surgical accuracy, reducing the risk of complications. Additionally, biocompatible implants made from titanium and 3D-printed porous materials are increasing the success rates of fusion procedures by promoting bone growth and stability. The use of biologics, such as bone graft substitutes and growth factors, is also enhancing fusion outcomes. These innovations are making sacroiliac joint fusion a more attractive option for both patients and healthcare providers.

Which Patient Groups And Healthcare Sectors Are Driving The Demand For SI Joint Fusion?

The primary patient groups benefiting from sacroiliac joint fusion include individuals suffering from chronic lower back pain, arthritis, trauma-related injuries, and post-pregnancy pelvic instability. Geriatric patients, who are more prone to degenerative joint conditions, represent a significant portion of the market. Additionally, athletes and individuals engaged in physically demanding jobs are at higher risk of SI joint dysfunction, increasing demand for surgical interventions. The hospital and ambulatory surgery center (ASC) sectors are experiencing heightened adoption of SI joint fusion procedures due to improved reimbursement policies and cost-effective outpatient surgical options. As more orthopedic specialists and pain management clinics incorporate SI joint fusion into their treatment offerings, the market is expected to expand further.

What Factors Are Fueling The Growth Of The Sacroiliac Joint Fusion Market?

The growth in the sacroiliac joint fusion market is driven by increasing awareness of SI joint dysfunction, advancements in minimally invasive surgery, and a rising aging population prone to degenerative joint diseases. The growing adoption of robotic-assisted procedures and image-guided navigation systems is improving surgical outcomes, further driving market adoption. Favorable reimbursement policies and increased healthcare expenditure on pain management solutions are also contributing to market growth. Additionally, the rising prevalence of sedentary lifestyles and obesity is increasing the incidence of lower back pain, prompting more patients to seek surgical solutions. As research continues to refine treatment approaches, the sacroiliac joint fusion market is poised for sustained expansion.

SCOPE OF STUDY:

The report analyzes the Sacroiliac Joint Fusion market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Indication (Degenerative Sacroiliitis, Sacral Disruption, Trauma); Treatment Type (Surgery, Injections, RF Ablation); End-Use (Hospitals, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Alphatec Spine, Inc.
  • Aurora Spine Corporation
  • Camber Spine Technologies, LLC
  • CoreLink Surgical
  • DePuy Synthes (Johnson & Johnson)
  • Globus Medical, Inc.
  • Integra LifeSciences Holdings Corp.
  • Life Spine, Inc.
  • Medacta International
  • Medtronic plc
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • PainTEQ
  • RTI Surgical Holdings, Inc.
  • SI-BONE, Inc.
  • SIGNUS Medizintechnik GmbH
  • VGI Medical
  • Xtant Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Zyga Technology, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP32859

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Sacroiliac Joint Fusion - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Lower Back Pain and Sacroiliac Joint Dysfunction Drives Demand for Sacroiliac Joint Fusion Procedures
    • Surge in Aging Populations and Degenerative Spine Disorders Expands Market Opportunity for Sacroiliac Joint Fusion Solutions
    • Rising Awareness and Acceptance of Minimally Invasive Surgical Techniques Propels Growth in Sacroiliac Joint Fusion Adoption
    • Technological Advancements in Sacroiliac Joint Fusion Implants and Devices Strengthen the Business Case for Surgery
    • Growing Preference for Outpatient and Same-Day Discharge Procedures Accelerates Adoption of Sacroiliac Joint Fusion Solutions
    • Increasing Investment in Spine Surgery Innovation and Research Expands Addressable Market for Sacroiliac Joint Fusion
    • Surge in Healthcare Spending and Investment in Surgical Infrastructure Drives Demand for Advanced Sacroiliac Joint Fusion Technologies
    • Rising Focus on Reducing Surgical Recovery Times and Enhancing Patient Outcomes Strengthens the Case for Sacroiliac Joint Fusion
    • Expansion of Surgical Options for Chronic Back Pain and Spinal Disorders Creates New Market Opportunities for Sacroiliac Joint Fusion
    • Increasing Utilization of Robotic-Assisted Surgery for Spine and Orthopedic Procedures Spurs Demand for Sacroiliac Joint Fusion Solutions
    • Regulatory Support and Clearer Approval Pathways for Sacroiliac Joint Fusion Devices Accelerate Product Adoption
    • The Shift Toward Personalized and Targeted Spine Surgery Solutions Drives Innovation in Sacroiliac Joint Fusion Technologies
    • Growing Popularity of Hybrid and Combination Procedures for Spinal Disorders Expands Market Demand for Sacroiliac Joint Fusion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sacroiliac Joint Fusion Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Sacroiliac Joint Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Degenerative Sacroiliitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Degenerative Sacroiliitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Degenerative Sacroiliitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Sacral Disruption by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Sacral Disruption by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Sacral Disruption by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Trauma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Trauma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Trauma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for RF Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for RF Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for RF Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • JAPAN
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • CHINA
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • EUROPE
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Sacroiliac Joint Fusion by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • FRANCE
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • GERMANY
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Sacroiliac Joint Fusion by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • INDIA
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Sacroiliac Joint Fusion by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Sacroiliac Joint Fusion by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • AFRICA
    • Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Sacroiliac Joint Fusion by Treatment Type - Surgery, Injections and RF Ablation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Sacroiliac Joint Fusion by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Injections and RF Ablation for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Sacroiliac Joint Fusion by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!